Antibiotic Resistance Market: Global Market Size, Forecast, Insights, Segmentation, and Competitive Landscape with Impact of COVID-19 & Russia-Ukraine War
The global antibiotic resistance market is expected to grow at a CAGR of around 5.4% during 2024-2033. This report on global antibiotic resistance market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the global antibiotic resistance market by segmenting the market based on disease, pathogen, drug class, distribution channel, and region. Also, detailed profiles of companies operating in the antibiotic resistance market are provided in this report. We believe that this report will aid the professionals and industry stakeholders in making informed decision.
Market Drivers
• Rising Government Initiatives
• Growing Developments in the Industry
Market Challenges
• Lack of Skilled Professionals
Historical & Forecast Period
Base Year: 2023
Historical Period: 2019-2023
Forecast Period: 2024-2033
Market by Disease
• Complicated Urinary Tract Infections
• Clostridioides Difficile Infection
• Acute Bacterial Skin and Skin Structure Infections
• Hospital-acquired bacterial Pneumonia
• Community-acquired Pneumonia
• Complicated intra-abdominal Infection
• Bloodstream Infection
Market by Pathogen
• Staphylococcus Aureis
• Streptococcus Pheumoniae
• Acinetobacter
• Enterococcus
• Hemophilus Influenzae
Market by Drug Class
• Oxazolidinones
• Lipoglycopeptides
• Tetracyclines
• Combination Therapies
• Cephalosporins
• Others
Market by Distribution Channel
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
Market by Region
• Europe
Germany
United Kingdom
France
Italy
Spain
Russia
Netherlands
Rest of Europe
• North America
United States
Canada
• Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Rest of Asia Pacific
• Latin America
Mexico
Brazil
Argentina
Rest of Latin America
• Middle East & Africa
Saudi Arabia
Turkey
Iran
United Arab Emirates
Rest of Middle East & Africa
- 1. Preface
- 1.1 Objective
- 1.2 Target Audience & Key Offerings
- 1.3 Report’s Scope
- 1.4 Research Methodology
- 1.4.1 Phase I
- 1.4.2 Phase II
- 1.4.3 Phase III
- 1.5 Assumptions
- 2. Key Insights
- 3. Global Antibiotic Resistance Market
- 3.1. Introduction
- 3.2. Market Drivers
- 3.3. Market Challenges
- 4. Global Antibiotic Resistance Market Analysis
- 4.1. Market Portraiture
- 4.2. Market Size
- 4.3. Market Forecast
- 4.4. Impact of COVID-19
- 4.5. Impact of Russia-Ukraine War
- 5. Global Antibiotic Resistance Market by Disease
- 5.1. Introduction
- 5.2. Complicated Urinary Tract Infections
- 5.3. Clostridioides Difficile Infection
- 5.4. Acute Bacterial Skin and Skin Structure Infections
- 5.5. Hospital-acquired bacterial Pneumonia
- 5.6. Community-acquired Pneumonia
- 5.7. Complicated intra-abdominal Infection
- 5.8. Bloodstream Infection
- 6. Global Antibiotic Resistance Market by Pathogen
- 6.1. Introduction
- 6.2. Staphylococcus Aureis
- 6.3. Streptococcus Pheumoniae
- 6.4. Acinetobacter
- 6.5. Enterococcus
- 6.6. Hemophilus Influenzae
- 7. Global Antibiotic Resistance Market by Drug Class
- 7.1. Introduction
- 7.2. Oxazolidinones
- 7.3. Lipoglycopeptides
- 7.4. Tetracyclines
- 7.5. Combination therapies
- 7.6. Cephalosporins
- 7.7. Others
- 8. Global Antibiotic Resistance Market by Distribution Channel
- 8.1. Food and Beverages
- 8.2. Hospital Pharmacies
- 8.3. Retail Pharmacies
- 8.4. Online Pharmacies
- 9. Global Antibiotic Resistance Market by Region
- 9.1. Introduction
- 9.2. Europe
- 9.2.1. Germany
- 9.2.2. United Kingdom
- 9.2.3. France
- 9.2.4. Italy
- 9.2.5. Spain
- 9.2.6. Russia
- 9.2.7. Netherlands
- 9.2.8. Rest of the Europe
- 9.3. North America
- 9.3.1. United States
- 9.3.2. Canada
- 9.4. Asia Pacific
- 9.4.1. China
- 9.4.2. Japan
- 9.4.3. India
- 9.4.4. South Korea
- 9.4.5. Australia
- 9.4.6. Indonesia
- 9.4.7. Rest of the Asia Pacific
- 9.5. Latin America
- 9.5.1. Mexico
- 9.5.2. Brazil
- 9.5.3. Argentina
- 9.5.4. Rest of Latin America
- 9.6. Middle East & Africa
- 9.6.1. Saudi Arabia
- 9.6.2. Turkey
- 9.6.3. Iran
- 9.6.4. United Arab Emirates
- 9.6.5. Rest of Middle East & Africa
- 10. SWOT Analysis
- 11. Porter’s Five Forces
- 12. Market Value Chain Analysis
- 13. Competitive Landscape
- 13.1. Competitive Scenario
- 13.2. Company Profiles
- 13.2.1. AbbVie Inc
- 13.2.2. Allergan
- 13.2.3. Basilea Pharmaceutica Ltd.
- 13.2.4. Entasis therapeutics
- 13.2.5. GlaxoSmithKline Plc
- 13.2.6. Melinta Therapeutics
- 13.2.7. Merck & Co. Inc.
- 13.2.8. Nemesis Bioscience Ltd
- 13.2.9. Novartis AG
- 13.2.10. Paratek Pharmaceuticals, Inc.
- 13.2.11. Pfizer Inc
- 13.2.12. Seres Therapeutics
- 13.2.13. Tetraphase Pharmaceuticals
- 13.2.14. Theravance Biopharma
- 13.2.15. Vertex Pharmaceuticals Incorporated
- List of Figures
- Figure 1: Global Antibiotic Resistance Market (in US$ Million), 2019-2023
- Figure 2: Global Antibiotic Resistance Market by Disease, 2023
- Figure 3: Global Antibiotic Resistance Market by Pathogen, 2023
- Figure 4: Global Antibiotic Resistance Market by Drug Class, 2023
- Figure 5: Global Antibiotic Resistance Market by Distribution Channel, 2023
- Figure 6: Global Antibiotic Resistance Market by Region, 2023
- Figure 7: Global Antibiotic Resistance Market (in US$ Million), 2024-2033
- Figure 8: Global Antibiotic Resistance Market by Disease (in %), 2023 & 2033
- Figure 9: Global Complicated Urinary Tract Infections Antibiotic Resistance Market (in US$ Million), 2019-2023
- Figure 10: Global Complicated Urinary Tract Infections Antibiotic Resistance Market (in US$ Million), 2024-2033
- Figure 11: Global Clostridioides Difficile Infection Antibiotic Resistance Market (in US$ Million), 2019-2023
- Figure 12: Global Clostridioides Difficile Infection Antibiotic Resistance Market (in US$ Million), 2024-2033
- Figure 13: Global Acute Bacterial Skin and Skin Structure Infections Antibiotic Resistance Market (in US$ Million), 2019-2023
- Figure 14: Global Acute Bacterial Skin and Skin Structure Infections Antibiotic Resistance Market (in US$ Million), 2024-2033
- Figure 15: Global Hospital-acquired bacterial Pneumonia Antibiotic Resistance Market (in US$ Million), 2019-2023
- Figure 16: Global Hospital-acquired bacterial Pneumonia Antibiotic Resistance Market (in US$ Million), 2024-2033
- Figure 17: Global Community-acquired Pneumonia Antibiotic Resistance Market (in US$ Million), 2019-2023
- Figure 18: Global Community-acquired Pneumonia Antibiotic Resistance Market (in US$ Million), 2024-2033
- Figure 19: Global Complicated intra-abdominal Infection Antibiotic Resistance Market (in US$ Million), 2019-2023
- Figure 20: Global Complicated intra-abdominal Infection Antibiotic Resistance Market (in US$ Million), 2024-2033
- Figure 21: Global Bloodstream Infection Antibiotic Resistance Market (in US$ Million), 2019-2023
- Figure 22: Global Bloodstream Infection Antibiotic Resistance Market (in US$ Million), 2024-2033
- Figure 23: Global Antibiotic Resistance Market by Pathogen (in %), 2023 & 2033
- Figure 24: Global Staphylococcus Aureis Antibiotic Resistance Market (in US$ Million), 2019-2023
- Figure 25: Global Staphylococcus Aureis Antibiotic Resistance Market (in US$ Million), 2024-2033
- Figure 26: Global Streptococcus Pheumoniae Antibiotic Resistance Market (in US$ Million), 2019-2023
- Figure 27: Global Streptococcus Pheumoniae Antibiotic Resistance Market (in US$ Million), 2024-2033
- Figure 28: Global Acinetobacter Antibiotic Resistance Market (in US$ Million), 2019-2023
- Figure 29: Global Acinetobacter Antibiotic Resistance Market (in US$ Million), 2024-2033
- Figure 30: Global Enterococcus Antibiotic Resistance Market (in US$ Million), 2019-2023
- Figure 31: Global Enterococcus Antibiotic Resistance Market (in US$ Million), 2024-2033
- Figure 32: Global Hemophilus Influenzae Antibiotic Resistance Market (in US$ Million), 2019-2023
- Figure 33: Global Hemophilus Influenzae Antibiotic Resistance Market (in US$ Million), 2024-2033
- Figure 34: Global Antibiotic Resistance Market by Drug Class (in %), 2023 & 2033
- Figure 35: Global Oxazolidinones Antibiotic Resistance Market (in US$ Million), 2019-2023
- Figure 36: Global Oxazolidinones Antibiotic Resistance Market (in US$ Million), 2024-2033
- Figure 37: Global Lipoglycopeptides Antibiotic Resistance Market (in US$ Million), 2019-2023
- Figure 38: Global Lipoglycopeptides Antibiotic Resistance Market (in US$ Million), 2024-2033
- Figure 39: Global Tetracyclines Antibiotic Resistance Market (in US$ Million), 2019-2023
- Figure 40: Global Tetracyclines Antibiotic Resistance Market (in US$ Million), 2024-2033
- Figure 41: Global Combination Therapies Antibiotic Resistance Market (in US$ Million), 2019-2023
- Figure 42: Global Combination Therapies Antibiotic Resistance Market (in US$ Million), 2024-2033
- Figure 43: Global Cephalosporins Therapies Antibiotic Resistance Market (in US$ Million), 2019-2023
- Figure 44: Global Cephalosporins Therapies Antibiotic Resistance Market (in US$ Million), 2024-2033
- Figure 45: Global Other Drug Class Antibiotic Resistance Market (in US$ Million), 2019-2023
- Figure 46: Global Other Drug Class Antibiotic Resistance Market (in US$ Million), 2024-2033
- Figure 47: Global Antibiotic Resistance Market by Distribution Channel (in %), 2023 & 2033
- Figure 48: Global Hospital Pharmacies Antibiotic Resistance Market (in US$ Million), 2019-2023
- Figure 49: Global Hospital Pharmacies Antibiotic Resistance Market (in US$ Million), 2024-2033
- Figure 50: Global Retail Pharmacies Antibiotic Resistance Market (in US$ Million), 2019-2023
- Figure 51: Global Retail Pharmacies Antibiotic Resistance Market (in US$ Million), 2024-2033
- Figure 52: Global Online Pharmacies Antibiotic Resistance Market (in US$ Million), 2019-2023
- Figure 53: Global Online Pharmacies Antibiotic Resistance Market (in US$ Million), 2024-2033
- Figure 54: Global Antibiotic Resistance Market by Region (in %), 2023 & 2033
- Figure 55: Europe Antibiotic Resistance Market (in US$ Million), 2019-2023
- Figure 56: Europe Antibiotic Resistance Market (in US$ Million), 2024-2033
- Figure 57: Europe Antibiotic Resistance Market by Country (in %), 2023 & 2033
- Figure 58: Germany Antibiotic Resistance Market (in US$ Million), 2019-2033
- Figure 59: United Kingdom Antibiotic Resistance Market (in US$ Million), 2019-2033
- Figure 60: France Antibiotic Resistance Market (in US$ Million), 2019-2033
- Figure 61: Italy Antibiotic Resistance Market (in US$ Million), 2019-2033
- Figure 62: Spain Antibiotic Resistance Market (in US$ Million), 2019-2033
- Figure 63: Russia Antibiotic Resistance Market (in US$ Million), 2019-2033
- Figure 64: Netherlands Antibiotic Resistance Market (in US$ Million), 2019-2033
- Figure 65: North America Antibiotic Resistance Market (in US$ Million), 2019-2023
- Figure 66: North America Antibiotic Resistance Market (in US$ Million), 2024-2033
- Figure 67: North America Antibiotic Resistance Market by Country (in %), 2023 & 2033
- Figure 68: United States Antibiotic Resistance Market (in US$ Million), 2019-2033
- Figure 69: Canada Antibiotic Resistance Market (in US$ Million), 2019-2033
- Figure 70: Asia Pacific Antibiotic Resistance Market (in US$ Million), 2019-2023
- Figure 71: Asia Pacific Antibiotic Resistance Market (in US$ Million), 2024-2033
- Figure 72: Asia Pacific Antibiotic Resistance Market by Country (in %), 2023 & 2033
- Figure 73: China Antibiotic Resistance Market (in US$ Million), 2019-2033
- Figure 74: Japan Antibiotic Resistance Market (in US$ Million), 2019-2033
- Figure 75: India Antibiotic Resistance Market (in US$ Million), 2019-2033
- Figure 76: South Korea Antibiotic Resistance Market (in US$ Million), 2019-2033
- Figure 77: Australia Antibiotic Resistance Market (in US$ Million), 2019-2033
- Figure 78: Indonesia Antibiotic Resistance Market (in US$ Million), 2019-2033
- Figure 79: Latin America Antibiotic Resistance Market (in US$ Million), 2019-2023
- Figure 80: Latin America Antibiotic Resistance Market (in US$ Million), 2024-2033
- Figure 81: Latin America Antibiotic Resistance Market by Country (in %), 2023 & 2033
- Figure 82: Mexico Antibiotic Resistance Market (in US$ Million), 2019-2033
- Figure 83: Brazil Antibiotic Resistance Market (in US$ Million), 2019-2033
- Figure 84: Argentina Antibiotic Resistance Market (in US$ Million), 2019-2033
- Figure 85: Middle East & Africa Antibiotic Resistance Market (in US$ Million), 2019-2023
- Figure 86: Middle East & Africa Antibiotic Resistance Market (in US$ Million), 2024-2033
- Figure 87: Middle East & Africa Antibiotic Resistance Market by Country (in %), 2023 & 2033
- Figure 88: Saudi Arabia Antibiotic Resistance Market (in US$ Million), 2019-2033
- Figure 89: Turkey Antibiotic Resistance Market (in US$ Million), 2019-2033
- Figure 90: Iran Antibiotic Resistance Market (in US$ Million), 2019-2033
- Figure 91: UAE Antibiotic Resistance Market (in US$ Million), 2019-2033
- Figure 92: Market Value Chain
- List of Tables
- Table 1: Global Antibiotic Resistance Market Portraiture
- Table 2: Global Antibiotic Resistance Market by Disease (in US$ Million), 2023 & 2033
- Table 3: Global Antibiotic Resistance Market by Pathogen (in US$ Million), 2023 & 2033
- Table 4: Global Antibiotic Resistance Market by Drug Class (in US$ Million), 2023 & 2033
- Table 5: Global Antibiotic Resistance Market by Distribution Channel (in US$ Million), 2023 & 2033
- Table 6: Global Antibiotic Resistance Market by Region (in US$ Million), 2023 & 2033
- Table 7: Europe Antibiotic Resistance Market by Country (in US$ Million), 2023 & 2033
- Table 8: North America Antibiotic Resistance Market by Country (in US$ Million), 2023 & 2033
- Table 9: Asia Pacific Antibiotic Resistance Market by Country (in US$ Million), 2023 & 2033
- Table 10: Latin America Antibiotic Resistance Market by Country (in US$ Million), 2023 & 2033
- Table 11: Middle East & Africa Antibiotic Resistance Market by Country (in US$ Million), 2023 & 2033
- Table 12: List of Key Players
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook